- Home
- SNY vs BTI Comparison
SNY vs BTI Comparison
Compare SNY & BTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- BTI
- Stock Information
- Founded
- SNY 1994
- BTI 1902
- Country
- SNY France
- BTI United Kingdom
- Employees
- SNY N/A
- BTI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- BTI Medicinal Chemicals and Botanical Products
- Sector
- SNY Health Care
- BTI Health Care
- Exchange
- SNY Nasdaq
- BTI Nasdaq
- Market Cap
- SNY 116.5B
- BTI 125.1B
- IPO Year
- SNY N/A
- BTI N/A
- Fundamental
- Price
- SNY $49.58
- BTI $55.25
- Analyst Decision
- SNY Buy
- BTI Strong Buy
- Analyst Count
- SNY 3
- BTI 2
- Target Price
- SNY $65.00
- BTI N/A
- AVG Volume (30 Days)
- SNY 2.3M
- BTI 4.5M
- Earning Date
- SNY 10-24-2025
- BTI 02-12-2026
- Dividend Yield
- SNY 3.23%
- BTI 5.53%
- EPS Growth
- SNY 118.56
- BTI N/A
- EPS
- SNY 8.65
- BTI 1.89
- Revenue
- SNY $53,714,621,258.00
- BTI $35,067,817,512.00
- Revenue This Year
- SNY $2.01
- BTI N/A
- Revenue Next Year
- SNY $6.82
- BTI $3.06
- P/E Ratio
- SNY $11.21
- BTI $29.28
- Revenue Growth
- SNY 15.65
- BTI N/A
- 52 Week Low
- SNY $44.73
- BTI $34.17
- 52 Week High
- SNY $60.12
- BTI $59.29
- Technical
- Relative Strength Index (RSI)
- SNY 51.60
- BTI 46.16
- Support Level
- SNY $50.07
- BTI $55.69
- Resistance Level
- SNY $51.60
- BTI $56.92
- Average True Range (ATR)
- SNY 0.61
- BTI 0.67
- MACD
- SNY 0.00
- BTI -0.54
- Stochastic Oscillator
- SNY 40.06
- BTI 15.02
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 518 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.